How does benztropine work in the brain?
Benztropine is an anticholinergic (antimuscarinic) drug. It works mainly by blocking muscarinic acetylcholine receptors in the central nervous system, which reduces acetylcholine activity [1]. This shifts the balance between cholinergic and dopaminergic signaling in the basal ganglia, helping lessen symptoms that involve excessive muscle rigidity and tremor.
Why does an anticholinergic help Parkinson’s symptoms?
In Parkinson’s disease, dopaminergic neurons degenerate, which indirectly increases relative cholinergic activity in the motor circuits. By blocking muscarinic receptors, benztropine counteracts that relative cholinergic excess. The result is reduced tremor and stiffness (and, for some patients, improved control of involuntary movements) [1].
How is benztropine used for drug-induced movement problems?
Benztropine is also used to treat extrapyramidal symptoms (EPS) caused by dopamine-blocking antipsychotics. Those drugs reduce dopaminergic signaling in the striatum, which again leaves cholinergic tone relatively higher. Benztropine lowers the effect of that increased cholinergic tone by muscarinic receptor blockade, reducing EPS such as acute dystonia and parkinsonism [1].
What effect does benztropine have on muscle rigidity and tremor?
Because it reduces central muscarinic (cholinergic) activity, benztropine tends to:
- decrease rigidity and tremor
- reduce some forms of dystonia and other extrapyramidal symptoms
These effects are tied to its antimuscarinic mechanism in the basal ganglia motor pathways [1].
What side effects link back to its anticholinergic mechanism?
Blocking muscarinic receptors can cause typical anticholinergic effects, which may include dry mouth, constipation, blurred vision, urinary retention, and cognitive effects (such as confusion), especially in older adults or at higher doses [1].
References
- DrugBank Online. Benztropine (mechanism of action and pharmacology). https://go.drugbank.com/drugs/DB01070